Antibiotics

It is produced by the strain of Streptomyces albireticuli. It has anti-gram positive bacteria and negative bacteria activity.

It is produced by the strain of Str. sp. AO-126. It has anti-gram positive bacteria and negative bacteria activity.

It is produced by the strain of Streptomyces violaceus A262. It has anti-gram positive, negative bacteria and candida albicans activity, and has anti-leukemic L1210 activity, which is stronger than Aclacinomycin.

It is produced by the strain of Streptomyces violaceus A262. It has anti-gram positive, negative bacteria and candida albicans activity, and has anti-leukemic L1210 activity, which is stronger than Aclacinomycin.

It is produced by the strain of Streptomyces violaceus A262. It has anti-gram positive, negative bacteria and candida albicans activity, and has anti-leukemic L1210 activity, which is stronger than Aclacinomycin.

It is produced by the strain of Streptomyces violaceus A262. It has anti-gram positive, negative bacteria and candida albicans activity, and has anti-leukemic L1210 activity, which is stronger than Aclacinomycin.

It is produced by the strain of Streptomyces violaceus A262. It has anti-gram positive, negative bacteria and candida albicans activity, and has anti-leukemic L1210 activity, which is stronger than Aclacinomycin.

It is produced by the strain of Epicoccum nigrum. It has activity against gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA) and vancomycin resistant enterococcus (VRE), MIC is 12.5-25 μg/mL. It also has effect on candida albicans with MIC of 25 μg/mL.

It is produced by the strain of Epicoccum nigrum. It has activity against gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA) and vancomycin resistant enterococcus (VRE), MIC is 12.5-25 μg/mL. It also has effect on candida albicans with MIC of 25 μg/mL.

It is produced by the strain of Streptomyces sp. C39. Gibbestatin B inhibits the expression of α-amylase induced by gibberellin in De-embryoned rice and barley (IC50 is 25-50 ppm, IC100 is 100-200 ppm), and has no anti-bacterial, anti-yeast and anti-fungal effects at 100 ppm (MIC, agar dilution method using bouillon agar for bacteria and Sabouraud agar for yeast and fungi).

It is produced by the strain of Streptomyces gilvotanareus, Str. anandii. It has anti-gram-positive bacterial activity and can inhibit sarcoma 180 and P388 leukemia cells.

It is produced by the strain of Streptomyces sp. It is an antibiotic with strong anti-tumor activity. It can inhibit P388, K562, A431 and MKN28 cells with IC50 (ng/mL) of 0.08, 0.86, 0.72 and 0.75, respectively.

It is produced by the strain of Polyangium brachysporum sp. No. K481-B-101. It is an anti-tumor antibiotic. It has the activity against pathogenic fungi and yeast, the activity of Glidobactin C is the strongest. It also extends the survival of mice inoculated with leukemia P388 cells.

It is produced by the strain of Polyangium brachysporum sp. No. K481-B-101. It is an anti-tumor antibiotic. It has the activity against pathogenic fungi and yeast, the activity of Glidobactin C is the strongest. Glidobactin C has anti-candida albicans and aspergillus fumigatus activity with MIC of 0.8 μg/mL. It also extends the survival of mice inoculated with leukemia P388 cells.

It is produced by the strain of Polyangium brachysporum sp. No. K481-B-101. It is an anti-tumor antibiotic. It has the activity against pathogenic fungi and yeast, the activity of Glidobactin C is the strongest. It also extends the survival of mice inoculated with leukemia P388 cells.

It is produced by the strain of Polyangium brachysporum sp. No. K481-B-101. It is an anti-tumor antibiotic. It has the activity against pathogenic fungi and yeast, the activity of Glidobactin C is the strongest. It also extends the survival of mice inoculated with leukemia P388 cells.

It is produced by the strain of Gliocladium virens SANK 12679, Chaetomium globosum SANK 13379, Trichoderma viride SANK 13479. It has anti-tumor activity.

It is produced by the strain of Glomospora sp. BAUA 2825. It is a cyclic ester peptide antifungal antibiotic, and it has moderate anti-aspergillus flavus (including aspergillus Niger and Aspergillus Niger), yeast activity (MIC is 16 μg/mL).

Glucoallosamidin A is a glycoside antibiotic produced by the strain of Streptomyces sp. SA-684. It can inhibit Chitinase activity.

Glucoallosamidin B is a glycoside antibiotic produced by the strain of Streptomyces sp. SA-684. It can inhibit Chitinase activity.